ClinicalTrials.gg
RecruitingNCT06566937Updated Aug 22, 2024

The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer Patients

An interventional study of E-health video in Breast Cancer, Breast Neoplasms and Depression, Anxiety, sponsored by National University of Malaysia. Recruiting at 1 site in Malaysia. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-08-22.

Sponsored by National University of Malaysia · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 62 studies in Breast Neoplasms with a site in Malaysia — 14 open to participants now, 27 under way, 19 of them phase 3. Breast Neoplasms · Malaysia.

Planned enrollment
47th of 59
114 · median 479
Started
2024
with 5 others
No phase
13 of 62
5 open now
Primary completion
2024-09
later than 2 of 26 live
Registered
56th of 62
by date

Among the 62 studies in Breast Neoplasms with a site in Malaysia, this one is the 47th largest by planned enrollment of the 59 interventional ones that give a count, is one of 6 that started in 2024, is one of 13 with no phase, reaches primary completion later than 2 of the 26 other live ones, and was the 56th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

14 of the 62 studies in Breast Neoplasms with a site in Malaysia are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Malaysia have not opened yet or have stopped. Only those recruiting at a site in Malaysia →

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 18 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 62 studies in Breast Neoplasms with a site in Malaysia, or all of them as a file.
02

Study summary

Study Purpose: The study aims to assess how effective e-health interventions are at improving mental health help-seeking intentions and behaviours among breast cancer patients.

Intervention: E-health interventions will be utilized to encourage patients to seek mental health support. These interventions are designed to be accessible and convenient, offering support and information through digital platforms.

Participants: The study will involve breast cancer patients between the ages of 18 and 65.

Key Objectives:

Primary Goal: To measure any changes in patients' intentions and actions to seek mental health support before and after using e-health interventions.

Secondary Goals: To explore how these interventions impact mental health literacy, reduce self-stigma, and identify barriers and facilitators to seeking help.

Comparison: The study will compare outcomes for patients using e-health tools against those receiving traditional care without digital interventions.

Expected Outcomes: Researchers anticipate that e-health interventions will improve mental health help-seeking behaviours, enhance understanding of mental health issues, and reduce the stigma associated with seeking support.

Significance: This study could demonstrate the potential of digital health tools to support mental well-being among breast cancer patients, providing new ways to access care and overcome traditional barriers to seeking mental health support.

Read the detailed description

Study Objective: The study seeks to explore how digital health interventions can enhance the willingness and actions of breast cancer patients to seek mental health support. With the rise of digital technology, there is a growing interest in how these tools can bridge gaps in healthcare access and provide timely support.

Context and Background: Breast cancer patients often face significant emotional and psychological challenges, which can affect their overall well-being and treatment outcomes. Traditional mental health services may not always be accessible due to physical, geographic, or psychological barriers. E-health interventions present an innovative solution by offering support through digital platforms that patients can access from the comfort of their homes.

Digital Interventions: These tools are designed to provide information, support, and motivation, encouraging patients to engage in mental health services.

Methodology:

Participants: The study will recruit breast cancer patients aged 18 to 65, providing a diverse representation of those affected by the condition.

Implementation: Participants will use digital interventions over a specified period, with regular assessments to monitor changes in their mental health help-seeking behaviours and intentions.

Data Collection: Researchers will track metrics such as changes in self-reported mental health literacy, attitudes toward seeking help, self-stigma on seeking help and mental help-seeking intention score.

Comparative Analysis: The study will include a control group receiving standard care without digital interventions to compare outcomes and measure the effectiveness of e-health tools.

Anticipated Benefits:

Accessibility: E-health tools can offer immediate access to resources and support, overcoming barriers such as distance and mobility.

Personalization: Digital platforms can tailor content and support to meet individual needs, enhancing engagement and effectiveness.

Empowerment: By providing information and resources, e-health interventions can empower patients to take proactive steps in managing their mental health.

Significance: The findings from this study could have significant implications for healthcare delivery, demonstrating the value of integrating digital solutions into patient care. Successful implementation of e-health interventions could lead to widespread adoption, improving mental health outcomes for breast cancer patients and potentially other patient groups facing similar challenges.

Conclusion: By leveraging the power of digital technology, this study aims to transform the landscape of mental health support for breast cancer patients, offering new pathways to care that is accessible, effective, and patient-centred.

03

Conditions studied

  • Breast Cancer
  • Breast Neoplasms
  • Depression, Anxiety
  • Distress, Emotional

Keywords

  • telemedicine
  • e-health
  • help-seeking intention
  • behaviour
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Breast cancer patients from all stages of the disease who are currently undergoing treatment at Institut Kanser Negara (IKN)
  • Age 18 years and above
  • Patients willing to participate
  • Patients understand either Malay or English language

Exclusion criteria

Exclusion Criteria:

  • Patients with breast cancer and to the brain
  • Patients who are diagnosed with mental illness
  • Patients with performance status 3 and above (based on The (ECOG) Scale of Performance Status)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

ECOG performance status

A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.

0
Fully active, no restrictions.
1
Limited in strenuous activity, but walking and able to do light work, such as housework or office work.
2
Walking and able to look after yourself, but unable to work; up and about more than half of waking hours.
3
Able to look after yourself only in part; in bed or a chair more than half of waking hours.
4
Unable to look after yourself at all; in bed or a chair all day.

Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
114 participants (estimated)

Study arms

  • Experimental
    Intervention

    Participants in this group will receive the e-health intervention

    Other: E-health video

  • No intervention
    Control

    Participants in the control group will receive standard care and Ministry of Health pamphlets without the digital intervention

Interventions

  • OtherE-health video

    Length: The video is approximately 10-15 minutes long, making it concise and easy to watch in one sitting. Visuals: Includes engaging visuals, such as animations, graphics, and real-life footage, to illustrate key concepts and keep viewers engaged. Tone: The tone is supportive, empathetic, and empowering, aiming to create a positive and encouraging atmosphere.

06

What researchers measure

Primary outcomes

  1. Mental Help-Seeking Intention

    Help-Seeking Intention: The likelihood or willingness of breast cancer patients to seek professional mental health services. The mental help-seeking intention will be assessed using the Theory of Planned Behaviour (TPB) questionnaires. The help-seeking intention will be measured on a 3-item scale. Responses will be rated on a 6-point Likert scale, with higher scores indicating higher levels of help-seeking intention.

    Time frame: baseline, 4 weeks and 12 weeks post intervention

  2. Mental Help-Seeking Behaviour

    The actual actions participants took to seek mental health services, such as contacting a mental health professional or accessing online resources. Mental help-seeking behaviour will be assessed by their behaviour of seeking or not seeking help, the answer will be yes or no

    Time frame: baseline, 4 weeks and 12 weeks post intervention

Secondary outcomes

  1. Mental Health Literacy

    Mental health literacy refers to the knowledge and beliefs about mental disorders that aid in their recognition, management, and prevention. Evaluation: Mental Health Literacy Scale (MHLS)

    Time frame: baseline, 4 weeks and 12 weeks post intervention

  2. Attitude of Seeking Help, Subjective Norms, Perceived Behavioural Control (PBC)

    Attitude towards help-seeking, subjective norms, as well as PBC, will be assessed using the TPB questionnaires Perceived behavioural control - PBC will be measured on a 3-item scale. Responses will be rated on a 6-point Likert scale, with higher scores indicating higher levels of behavioural control Subjective norms - The subjective norm will be measured on a 3-item scale. Responses will be rated on a 6-point Likert scale, with higher scores indicating higher levels of subjective norm. Attitude towards help-seeking - This aspect will be assessed using 5 items, which will then be evaluated on a 6-point semantic differential scale, where higher scores denote a more favourable attitude towards help-seeking.

    Time frame: baseline, 4 weeks and 12 weeks post intervention

  3. Self-stigma of seeking help

    Self-stigma refers to the internalized negative perceptions and shame associated with seeking mental health support. Self-stigma in seeking help will be assessed using the Self-Stigma of Seeking Help (SSOSH) questionnaire

    Time frame: baseline, 4 weeks and 12 weeks post intervention

  4. Anxiety and Depression

    The level of anxiety and depression will be measured using the Hospital Anxiety and Depression Scale (HADS). HADS is a self-reported questionnaire designed to screen anxiety and depressive in a hospital setting

    Time frame: baseline, 4 weeks and 12 weeks post intervention

07

Study locations

1 of 1 sites recruiting
  • Institut Kanser Negara
    Putrajaya, 62250, Malaysia
    Recruiting
    • Nur Liyana Shamsudin · Contactwhiterosesmy@gmail.com · 60174203728
    • Nurdiana Hussin · Sub investigator
    • Azmawati Mohammed Nawi · Principal investigator
    • Idayu Badilla Idrus · Sub investigator
    • Nik Ruzyanei Nik Jaafar · Sub investigator
    • Nur Liyana Shamsudin · Sub investigator
    • Suhana Yusak · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Sep 2024, 1 month after the start.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 1 month is below that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2024
First posted
Aug 22, 2024
StartActual
Aug 9, 2024
Primary completionEst.
Sep 30, 2024
CompletionEst.
Sep 30, 2026
Last update
Aug 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06566937
Responsible party
Sponsor
First posted
Aug 22, 2024
Start date
Aug 9, 2024
Primary completion
Sep 30, 2024 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Aug 22, 2024

Study contacts

Azmawati Nawi
Contact
azmawati@ppukm.ukm.edu.my
60193131340
Nurdiana Hussin
Contact
dr.nurdiana@gmail.com
60167734458
Azmawati Mohammed Nawi
principal investigator · The National University of Malaysia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion